MyIgSource Answers and Advocates

Get access to insurance & financial support, educational resources & tools, and Patient & Nurse Advocates to help you understand and manage your Primary Immunodeficiency (PI).

Learn More   Enroll Now




  • Educate Yourself

    Having a better understanding of your condition is an important part of managing it.

    Learn More About PI
    Learn More About MMN

    Take an Active Role

    Manage your treatment by learning how you can be more involved in your care.

    Get Started Now
    Learn More About MMN
  • GAMMAGARD LIQUID Treatment

    For PI: See which method of administration may be right for you. Learn more.

    For MMN: Learn more about the first and only MMN treatment for adults that improved functioning by effectively maintaining and improving muscle strength, and reducing disability, compared to placebo.1

  • MyIgCoPayCard

    Patients with Primary Immunodeficiency (PI) can now save up to $5000* within a 12-month period on their out of pocket co-pay, co-insurance, or deductible for medication costs with MyIgCoPayCard.

    See If You Qualify

    *Subject to eligibility and restrictions apply.
    See Terms and Conditions

Reference: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information].
Westlake Village, CA: Baxalta US Inc.

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.

-----

Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.


© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.

Selected Important Safety Information for GAMMAGARD LIQUID
  • GAMMAGARD LIQUID can cause decreased kidney function or kidney failure, blood clots in the heart, brain, lungs or elsewhere in the body. Call your healthcare professional or go to your emergency department right away if you have: Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem. Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
  • Do not take GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to IgG or other blood products.